Comparison of Two Preservative-Free Artificial Tears with Sodium Hyaluronate for Relief of Dry Eye Symptoms: A Randomized, Investigator-Masked Study
Including medium-chain TGs in dry eye drops provides noninferior improvements of dry eye signs and symptoms versus viscosity agent-only drops and may enhance patient QoL.
Authors
- Kostas Boboridis (ORCID: https://orcid.org/0000-0002-0471-0371)
- Marc Labétoulle (ORCID: https://orcid.org/0000-0002-1680-1887)
- Ömür Uçakhan-Gündüz
- Stephanie C. Joachim (ORCID: https://orcid.org/0000-0001-7056-0829)
- José Manuel Benítez del Castillo
Institutions
- Universidad Complutense de Madrid (ES)
- Ankara University (TR)
- Inserm (FR)
- Aristotle University of Thessaloniki (GR)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- Université Paris-Saclay (FR)
- Hospital Clínico San Carlos (ES)
- Clínica Rementería (ES)
- CEA Paris-Saclay - Etablissement de Fontenay-aux-roses (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- CEA Paris-Saclay (FR)
- Infectious Disease Models and Innovative Therapies (FR)
- Bicêtre Hospital (FR)
- Ruhr University Bochum (DE)
Publication Details
- Journal
- Journal of Ocular Pharmacology and Therapeutics
- Published
- 2025-11-29
- DOI
- https://doi.org/10.1177/10807683251391557
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 0.00